Publication:
Impact of the Latest Clinical Data among Patients with Breast Cancer in Low- and Middle-Income Countries

Simple item page
dc.contributor.authorDawood, Shaheenah
dc.date.accessioned2023-05-09T05:38:44Z
dc.date.available2023-05-09T05:38:44Z
dc.date.issued2022-12
dc.description.abstractIntroduction: In June 2022, experts from the oncology world gathered in Chicago, Illinois, for the American Society of Clinical Oncology (ASCO) 2022 annual meeting. In this article, we review the latest advancements presented at the conference regarding metastatic breast cancer [1]. Then, with experts in the field, we discuss the scientific findings from the studies presented and the practical implications of these data among breast cancer patients in low- and middle-income countries.en_US
dc.identifier.other204-2022.211 Shaheenah Dawood
dc.identifier.urihttps://repository.mbru.ac.ae/handle/1/1250
dc.language.isoenen_US
dc.subjectASCOen_US
dc.subjectPalbocicliben_US
dc.subjectSacituzumaben_US
dc.subjectTrastuzumaben_US
dc.subjectPembrolizumaben_US
dc.subjectDenosumaben_US
dc.titleImpact of the Latest Clinical Data among Patients with Breast Cancer in Low- and Middle-Income Countriesen_US
dc.typeArticleen_US
dspace.entity.typePublicationen_US

Files

Collections

Faculty Publications (CoM)